| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239247 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
High-dose continuous hyperfractionated accelerated radiotherapy up to a dose of 68.40 Gy/38 fractions/25 days (a biologic equivalent of approximately 80 Gy when delivered in conventional fractionation) in patients with inoperable NSCLC and a V20 up to 37% is feasible.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Dirk M.D., Ph.D., Rinus M.D., Erik M.D., Ph.D., Monique M.D., Ph.D., Wiel M.D., Cordula M.D., Ph.D., Jean M.D., Ph.D., Liesbeth M.D., Ph.D., Tom M.D., Andre M.Sc., Ph.D., Søren M. M.Sc., Ph.D., Philippe M.D., Ph.D.,